Ahead Therapeutics will participate in the 4TH Antigen-specific immune tolerance summit -2021- 26-28 January

Ahead’s team will join the virtual version of ASIT summit this year.

The 4th Antigen-Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology, and transplantation to tackle the complexities behind autoimmune disorders head on. With momentum building for antigen-specific immunotherapies, ASIT 2021 will be the only antigen-specific summit offering thought-leading content to drive the field towards a more precise and ethical antigen-specific approach to drug development. (https://as-immunetolerance.com)